Patents by Inventor Brandon MA

Brandon MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952636
    Abstract: The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SNPs associated with resistance or susceptibility to antibiotic treatment of organism infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: April 9, 2024
    Assignee: Visby Medical, Inc.
    Inventors: Brian Ciopyk, Paul Dentinger, Teresa Abraham, Brandon Ma, Kamal Kajouke, Mackenzie Hunt, Austin Phung, Karl Guegler, David Swenson, Anna H. Postlethwaite
  • Patent number: 11941978
    Abstract: Traffic signal timing plans are derived from vehicle trajectory or probe data. The probe data is collected and archived in a datastore over a sample time on the order of weeks or longer. Probe data is corrected for clock drift, geo-fence filtered to a selected intersection, and then stop line crossings in the intersection are identified and analyzed along with related data to determine the timing plans and schedule for the intersection. In this way, access to government agency timing plans is obviated so as to save time and expense.
    Type: Grant
    Filed: September 17, 2022
    Date of Patent: March 26, 2024
    Assignee: TRAFFIC TECHNOLOGY SERVICES, INC.
    Inventors: Justin Michael Neill, Brandon Keith Sams, Jonah Aaron Pincetich, Darryl Joseph Michaud, Thomas Bauer, Jingtao Ma
  • Publication number: 20220372557
    Abstract: The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SN Ps associated with resistance or susceptibility to antibiotic treatment of organism infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.
    Type: Application
    Filed: May 6, 2022
    Publication date: November 24, 2022
    Inventors: Brian CIOPYK, Paul DENTINGER, Teresa ABRAHAM, Brandon MA, Kamal KAJOUKE, Mackenzie HUNT, Austin PHUNG
  • Publication number: 20220203365
    Abstract: In some embodiments, a stand-alone molecular diagnostic test device includes a detection circuit that includes a light emitting device and a light receiving device (e.g., a photodiode) that are arranged to produce an electronic signal associated with a colorimetric output produced by the stand-alone molecular diagnostic test.
    Type: Application
    Filed: April 28, 2020
    Publication date: June 30, 2022
    Applicant: Visby Medical, Inc.
    Inventors: Teresa ABRAHAM, Victor BRIONES, Brian CIOPYK, Paul DENTINGER, Kamal KAJOUKE, Bryan D. KNYSH, Brandon MA
  • Patent number: 11352675
    Abstract: The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SNPs associated with resistance or susceptibility to antibiotic treatment of organism infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: June 7, 2022
    Assignee: VISBY MEDICAL, INC.
    Inventors: Brian Ciopyk, Paul Dentinger, Teresa Abraham, Brandon Ma, Kamal Kajouke, Mackenzie Hunt, Austin Phung
  • Publication number: 20210207194
    Abstract: The disclosure relates generally to molecular diagnostic devices configured to amplifying a single nucleotide polymorphism (SNP) locus and discriminate between two or more allelic variants of the SNP, indicating presence or absence of a target allele. In some embodiments, the molecular diagnostic devices are capable of detecting, at point-of-care, SNPs associated with resistance or susceptibility to antibiotic treatment of organism infections. In other aspects, the disclosure provides methods of treatment for disease or disorders (e.g. organism infections) where treatment is guided by presence or absence of an allele at a SNP locus as determined by such molecular diagnostic devices.
    Type: Application
    Filed: December 31, 2020
    Publication date: July 8, 2021
    Inventors: Brian CIOPYK, Paul DENTINGER, Teresa ABRAHAM, Brandon MA, Kamal KAJOUKE, Mackenzie HUNT, Austin PHUNG